Screener
Castle Biosciences CSTL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| ASSETS | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value per share; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 30,295,965 and 29,686,314 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 30 | 30 |
| Additional paid-in capital | 700,255 | 694,860 |
| Accumulated deficit | (238,806) | (224,284) |
| Accumulated other comprehensive (loss) income | (63) | 267 |
| Total stockholders’ equity | 461,416 | 470,873 |
| Total liabilities and stockholders’ equity | $547,805 | $578,556 |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's retained earnings?
- Castle Biosciences (CSTL) reported retained earnings of -$238.81M in Q1 2026.
- How has Castle Biosciences's retained earnings changed year-over-year?
- Castle Biosciences's retained earnings decreased by 5.7% year-over-year, from -$225.97M to -$238.81M.
- What is the long-term trend for Castle Biosciences's retained earnings?
- Over 5 years (2020 to 2025), Castle Biosciences's retained earnings has grown at a 29.1% compound annual growth rate (CAGR), from -$62.5M to -$224.28M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Castle Biosciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude